Skip to content

EMBOLD™ Soft M001394250060300Recalls & reported problems

Boston Scientific Corporation · Detachable Coil System · Class 2 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00191506026547), received between Mar 16, 2026 and Mar 16, 2026 — classified as 1 malfunction.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break1
  • Malposition of Device1
  • Material Protrusion/Extrusion1
  • Premature Activation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 16, 2026Break; Premature Activation; Malposition of Device; Material Protrusion/Extrusion

    IT WAS REPORTED THAT THE COIL PREMATURELY DEPLOYED, AND PROTRUDED FROM THE TARGET LESION. AN EMBOLD SOFT 6X30 WAS SELECTED FOR USE TO TREAT A GASTROINTESTINAL BLEED. THE TARGET LESION WAS LOCATED IN THE MILDLY TORTUOUS AND CALCIFIED GASTRODUODENAL ARTERY (GDA), WHICH WAS 6 MM IN DIAMETER. DURING USE OF THE EMBOLD SOFT 6X30, THE COIL DEPLOYED PREMATURELY WITHIN THE MICROCATHETER WITHOUT BREAKING THE PROXIMAL RELEASE PERFORATION. AS A RESULT, THE PHYSICIAN WAS UNABLE TO POSITION THE COIL PRECISELY WITHIN THE TARGET LESION. THE PHYSICIAN WAS ABLE TO PUSH THE COIL OUT OF THE MICROCATHETER, BUT A PORTION OF THE COIL EXTENDED FROM THE GDA INTO THE HEPATIC ARTERY. THERE WAS NO ADDITIONAL INTERVENTION PERFORMED, AND NO PATIENT COMPLICATIONS AS A RESULT OF THIS EVENT. THE PATIENT WAS EXPECTED TO RECOVER FULLY. IT WAS FURTHER CLARIFIED THAT THE COIL BROKE WITHIN THE MICROCATHETER AT THE COUPLER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24606925 ↗

Other Device, Vascular, for Promoting Embolization devices

All Device, Vascular, for Promoting Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page